Literature DB >> 1933943

Changes in the expression of lectins in human T lymphocyte membrane upon mitogenic stimulation.

C Grillon1, M Monsigny, C Kieda.   

Abstract

Surface lectins, specific for given sugar structures, are expressed on human T cells, as shown by flow cytofluorometry using F-neoglycoproteins bearing either beta- and alpha-D-galactosyl, beta-D-galactosyl 6-phosphate, or alpha-L-rhamnosyl groups, but not by F-neoglycoproteins bearing other sugar groups (such as alpha-D-mannosyl groups). After stimulation with Phaseolus vulgaris mitogen, the number of cells that bind beta-D-galactosyl 6-phosphate groups (6-P-beta-D-Galp lec+ cells) increased fourfold during the first five days; these cells are helper (CD4+) T cells. Conversely, cells that bind alpha-L-Rha groups belong to the T suppressor (CD8+) family and their number moderately increased. Upon stimulation by concanavalin A, the number of cells expressing the lectin recognizing alpha-L-Rha groups increased during the first two days and then decreased within the next two days. These results are discussed with regard to the implication of lymphocyte membrane lectins in the suppressor mechanism and in the homing process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933943     DOI: 10.1016/s0008-6215(00)90615-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Cell-surface changes in cadmium-resistant Euglena: studies using lectin-binding techniques and flow cytometry.

Authors:  J Bonaly; E Brochiero
Journal:  Bull Environ Contam Toxicol       Date:  1994-01       Impact factor: 2.151

2.  Influence of 5 major Salmonella pathogenicity islands on NK cell depletion in mice infected with Salmonella enterica serovar Enteritidis.

Authors:  Daniela Karasova; Alena Sebkova; Hana Havlickova; Frantisek Sisak; Jiri Volf; Martin Faldyna; Petra Ondrackova; Vladimir Kummer; Ivan Rychlik
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.